FDAFDA · Food and drugs·Recall number D-0789-2020
Moxifloxacin Ophthalmic Solution USP, 0.5%, Sterile, 3mL Bottle, Rx Only, For Topical Ophthalmic Use Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, Made in India, NDC 65862-840-03.
Published January 22, 2020 · Recall initiated: December 2, 2019
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Discoloration: Market complaints of discoloration in Moxifloxacin Ophthalmic Solution.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- MOXIFLOXACIN
- Manufacturer
- AuroMedics Pharma LLC
- Distributor
- Nationwide in the U.S.
- UPC
- 0365862840035
- Lot
- Lot #s: CMF190008; CMF190009, Exp. 04/2021; CMF190025; CMF190026, Exp. 06/2021.
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.